OTC · PURE

Pure Bioscience, Inc.

Closing price No closing price on file for PURE from our free price source.

Latest quarter · ended Jul 31, 2026

Sales slipped and cash got weaker

descriptionFiled Oct 29, 2026
Revenue growthShrinking
−13.6%
Quarter ended Oct 31, 2024: −22.7% sales vs. a year beforeQuarter ended Jan 31, 2025: +20.3% sales vs. a year beforeQuarter ended Apr 30, 2025: +11.1% sales vs. a year beforeQuarter ended Jul 31, 2025: +61.7% sales vs. a year beforeQuarter ended Oct 31, 2025: +27.4% sales vs. a year beforeQuarter ended Jan 31, 2026: +13.3% sales vs. a year beforeQuarter ended Apr 30, 2026: +3.5% sales vs. a year beforeQuarter ended Jul 31, 2026: −13.6% sales vs. a year before
Oct '24Jul '26
$659K vs. $763K a year ago
Gross marginWorse
56.0%
Quarter ended Oct 31, 2024: 58.6% gross marginQuarter ended Jan 31, 2025: 58.1% gross marginQuarter ended Apr 30, 2025: 57.9% gross marginQuarter ended Jul 31, 2025: 61.3% gross marginQuarter ended Oct 31, 2025: 63.6% gross marginQuarter ended Jan 31, 2026: 53.7% gross marginQuarter ended Apr 30, 2026: 53.2% gross marginQuarter ended Jul 31, 2026: 56.0% gross margin
Oct '24Jul '26
vs. 61.3% a year ago
Cash from operationsBetter
−$414K
Quarter ended Oct 31, 2024: −$503K cash from operationsQuarter ended Jan 31, 2025: −$544K cash from operationsQuarter ended Apr 30, 2025: −$512K cash from operationsQuarter ended Jul 31, 2025: −$456K cash from operationsQuarter ended Oct 31, 2025: −$250K cash from operationsQuarter ended Jan 31, 2026: −$606K cash from operationsQuarter ended Apr 30, 2026: −$468K cash from operationsQuarter ended Jul 31, 2026: −$414K cash from operations
Oct '24Jul '26
vs. −$456K a year ago
Share countDiluting
+25.3%
Quarter ended Oct 31, 2024: 111.86M sharesQuarter ended Jan 31, 2025: 111.86M sharesQuarter ended Apr 30, 2025: 111.89M sharesQuarter ended Jul 31, 2025: 111.89M sharesQuarter ended Oct 31, 2025: 111.89M sharesQuarter ended Jan 31, 2026: 111.89M sharesQuarter ended Apr 30, 2026: 130.02M sharesQuarter ended Jul 31, 2026: 140.2M shares
Oct '24Jul '26
140.2M shares vs. 111.89M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Insider trades · last 12 months

Real buys and sales

No insider filings loaded for the last 12 months.

Top holders

Biggest funds in PURE

No 13F holdings loaded for this stock.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist